The Collaboration Between Doctors, Nurses, and Pharmacists in Optimizing Medication Management for Cardiac Emergency Patients
Collaboration Between Doctors, Nurses, and Pharmacists in Optimizing Medication Management for Cardiac Emergency Patients
DOI:
https://doi.org/10.35451/jkg.v6i2.2507Keywords:
Optimization, Management, Emergency, CardiacAbstract
Cardiac emergencies, such as acute myocardial infarction (IMA), acute heart failure, and severe arrhythmias, are conditions that require immediate intervention to save the patient's life.b Appropriate drug management in these situations plays a crucial role in stabilizing the patient's condition, reducing the risk of complications, and improving clinical outcomes. However, the effectiveness of drug therapy in emergencies depends not only on the selection of the right drug, but also on how it is comprehensively managed by a medical team consisting of doctors, nurses, and pharmacists. Collaboration between doctors, nurses, and pharmacists in medication management in cardiac emergency patients aims to improve the speed, safety, and effectiveness of therapy. Nurses administer medications and monitor patient response, pharmacists ensure proper dosing, prevent drug interactions, and provide education. Effective collaboration reduces the risk of medicationerrors, improves patient safety, and ensures optimal therapy through good communication and systematic coordination. Good collaboration between doctors, nurses, and pharmacists is essential in the medication management of cardiac emergency patients. With effective communication and good coordination, therapy can be delivered more quickly, safely, and optimally
Downloads
References
Page, R. L., O’Bryant, C. L., Cheng, D., et al. (2016). Drugs That May Cause or Exacerbate Heart Failure: A Scientific Statement From the American Heart Association. Circulation, 134(6), e32–e69. https://doi.org/10.1161/CIR.000000 0000000426 [3] Kirchhof, P.,
Benussi, S., Kotecha, D., et al. (2016). 2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration with EACTS. Eur Heart J, 37(38), 2893–
Kurniasih, D. A. A., Sintia, I., Syania, S., Andini, H., Setiawati, E. P., & Subarnas, A. (2022). Peran Apoteker dalam Kolaborasi Interprofesi: Studi Literatur. Majalah Farmaseutik, 18(1), 72–80
Kirchhof, P., Benussi, S., Kotecha, D., et al. (2016). 2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration with EACTS. Eur Heart J, 37(38),2893– 2962.
https://doi.org/10.1093/eurheartj/e hw210
Patel, M. R., Dehmer, G. J., Hirshfeld, J. W., et al. (2017). ACCF/SCAI/STS/AATS/AHA/ASNC
Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease. J Am
Coll Cardiol, 69(17), 2212–2241. https://doi.org/10.1016/j.jacc.2017. 02.001
Kurniasih, D. A. A., Sintia, I., Syania, S., Andini, H., Setiawati, E. P., & Subarnas, A. (2022). Peran Apoteker dalam Kolaborasi Interprofesi: Studi Literatur. Majalah Farmaseutik, 18(1), 72–80.
Arnanda, D. F., & Sumiwi, S. A. (2021). Bentuk Kolaborasi Interprofesional Apoteker dalam Meningkatkan Luaran Terapi Pasien. Farmaka, 19(2), 133–142.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Adikia Andreas
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright in each article is the property of the Author.
